RNS Number : 8447H
Tristel PLC
18 November 2025
TRISTEL plc
("Tristel" or the "Company")
Notice of AGM and Posting of Annual Report and Accounts
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Notice of Annual General Meeting ("AGM") and the 2025 Annual Report and Accounts for the year ended 30 June 2025 have been posted to shareholders yesterday and is available to download from the investor section of Company's website - https://investors.tristel.com/financial/
The Company's AGM will be held on Thursday 11 December 2025 at 11.00am at the Company's headquarters, Unit 1b Lynx Business Park, Fordham Road Snailwell, Newmarket, Cambridgeshire, CB8 7NY.
For further information please contact:
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets double digit revenue growth annually and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOAUBUORVOUAAAA
